Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction
- 31 August 1988
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 12 (2) , 519-525
- https://doi.org/10.1016/0735-1097(88)90429-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Intermittent Coronary Occlusion in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- An Interim Report of the Efficacy and Safety of Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)1Drugs, 1987
- Evidence for a Sustained Fibrinolytic Response to Anisoylated Plasminogen Streptokinase Activator Complex in VitroDrugs, 1987
- Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator ComplexDrugs, 1987
- High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: Description of effects in the circulationThe American Journal of Cardiology, 1986
- Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1985
- Molecular Defects in Interactions of Platelets with the Vessel WallNew England Journal of Medicine, 1984